Skip to content

Evaluation of dressing for central venous catheter

Evaluation of the effectiveness of the chlorhexidine antimicrobial dressing for central venous catheter - : ClorHexidine Gluconate-Central Venous Catheter

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7b5ycz
Enrollment
Unknown
Registered
2012-04-26
Start date
2011-10-17
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related bloodstream infection

Interventions

84 patients using the first central venous catheter within 24 hours of insertion of the short-term catheter will be randomized to form two groups. Study group: 42 patients receive curative antimicrobi
other

Sponsors

Universidade Federal do Paraná
Lead Sponsor
3M do Brasil
Collaborator

Eligibility

Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Over 18 years; Hospitalization in the Intensive Care Unit (ICU) or Semi Intensive (CTSI) Adult; In the first use of central venous catheter (CVC) for short stay less than 24 hours; Signing the consent form; No known sensitivity to materials of the dressings.

Exclusion criteria

Exclusion criteria: Refusal by the patient or explained by the family to participate in the research; By shaving blade at the site of catheter insertion prior to puncture; Sweating or bleeding from the orifice of the catheter; Temperature above 38 ° C during puncture of the catheter.

Design outcomes

Primary

MeasureTime frame
Reduction of bloodstream infection related to the catheter by the use of antimicrobial chlorhexidine dressings as measured by infection rate per thousand catheter days in both groups.

Secondary

MeasureTime frame
Increased rate of fixation of the skin healing evaluated by displacement of borders with or without compromising the integrity of the dressing. Will be considered adequate fixation when the dressing remains intact.;Reduction of local reaction to the healing assessed by the absence of itching, redness, scaling and maceration in the region of contact with skin healing.

Countries

Brazil

Contacts

Public ContactEdivane Pedrolo

Universidade Federal do Paraná

edivanepedrolo@gmail.com41 99255226

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Mar 7, 2026